India’s Leading Specialized PCD Pharma Franchise Platform
At Cafoli Lifecare, we provide 100% documented monopoly rights at the district level through a strictly ethical and transparent agreement. Our primary mission is to eliminate intra-brand competition, ensuring your market territory remains exclusively yours. As one of India’s fastest-growing PCD platforms, we maintain a presence in 300+ districts with a massive portfolio of 1,500+ DCGI-approved products—a range rapidly expanding toward 2,000+ formulations.
Why Cafoli Chose the "Division Path" for Your Business Growth
We believe that when our partners grow, we grow. Managing a catalog of 1,500+ medicines can be overwhelming; therefore, to save your energy and simplify your operations, Cafoli has strategically categorized its products into 12+ specialized therapeutic divisions.
By adopting this structure, we ensure you spend your time growing your business rather than fixing product-selection problems. Whether you are targeting Cardiology, Pediatrics, or Gynecology, our divisions allow you to present a professional, focused, and organized portfolio to doctors.
To further guarantee market acceptance, we manufacture exclusively through India’s most reputed WHO-GMP and ISO 9001:2015 certified units, including: Akums, Hetero, Tirupati, Sanzyme, Mascot, Windlas, Synokem, Biodial, and Bioaltus.
Explore Our Specialized Divisions
Click on a division below to view the full product range and technical descriptions: